Brought to you by 
CV Therapeutics brings in $175mm with debt offering
25 Apr 2000
Executive Summary
CV Therapeutics (small-molecule drugs for cardiovascular disease) has completed a private placement of $196.25mm in subordinated notes (including the overallotment) due in 2007, with interest of 4.75% annually, convertible into CVT common at $63.84 per share. The company had originally expected to bring in $125mm.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CV Therapeutics brings in $175mm with debt offering
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice